ロード中...
Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF
BACKGROUND: Multiple physiologic impairments are responsible for chronic wounds. A cell line grown which retains its phenotype from patient wounds would provide means of testing new therapies. Clinical information on patients from whom cells were grown can provide insights into mechanisms of specifi...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2621139/ https://ncbi.nlm.nih.gov/pubmed/19046453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-75 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|